Applications of ¹⁹F-NMR in Fragment-Based Drug Discovery

By Norton Raymond S.   Leung Eleanor W. W.   Chandrashekaran Indu R.   MacRaild Christopher A.  

Molecules, Vol. 21, Iss. 7, 2016-07 ,pp. : 860-860

MDPI

Access to resources Recommend Favorite

Integration of Ligand-Based Drug Screening with Structure-Based Drug Screening by Combining Maximum Volume Overlapping Score with Ligand Docking

By Fukunishi Yoshifumi   Nakamura Haruki  

Pharmaceuticals, Vol. 5, Iss. 12, 2012-12 ,pp. : 1332-1345

MDPI

Access to resources Recommend Favorite

Virtual Lead Identification of Farnesyltransferase Inhibitors Based on Ligand and Structure-Based Pharmacophore Techniques

By Al-Balas Qosay A.   Amawi Haneen A.   Hassan Mohammad A.   Qandil Amjad M.   Almaaytah Ammar M.   Mhaidat Nizar M.  

Pharmaceuticals, Vol. 6, Iss. 6, 2013-05 ,pp. : 700-715

MDPI

Access to resources Recommend Favorite

Discovery of Akt Kinase Inhibitors through Structure-Based Virtual Screening and Their Evaluation as Potential Anticancer Agents

By Chuang Chih-Hung   Cheng Ta-Chun   Leu Yu-Ling   Chuang Kuo-Hsiang   Tzou Shey-Cherng   Chen Chien-Shu  

International Journal of Molecular Sciences, Vol. 16, Iss. 2, 2015-02 ,pp. : 3202-3212

MDPI

Access to resources Recommend Favorite

Structure-Based Discovery of a Series of 5H-Pyrrolo[2,3-b]pyrazine FGFR Kinase Inhibitors

By Jiang Alan   Liu Qiufeng   Wang Ruifeng   Wei Peng   Dai Yang   Wang Xin   Xu Yechun   Ma Yuchi   Ai Jing   Shen Jingkang   Ding Jian   Xiong Bing  

Molecules, Vol. 23, Iss. 3, 2018-03 ,pp. : 698-698

MDPI

Access to resources Recommend Favorite